Summary
This study was originally designed to investigate wheter there is any correlation between the type of procoagulant activity (PCA) and the tumorigenicity of transformed cells. The data obtained are relevant to this question and to defining the differences in the expression of cellular activities depending on the in vitro system used. PCA was measured and characterized in normal, immortalized, and tumorigenic mouse fibroblasts. In all the lines studied the activity was of tissue factor type, as established with functional, enzymatic, and immunochemical criteria. However, the PCA of cells freshly isolated from the tumors induced by tumorigenic cell lines was of cancer procoagulant type, i.e. a cysteine protease with direct factor X activator activity. The same cells, when cultured in vitro, expressed again PCA of tissue-factor type. These results suggest that either a tumor-host interaction is required for the expression of cancer procoagulant or the latter activity, produced by tumor cells under in vitro conditions, is destroyed or inactivated during the culture period. Our findings caution against defining the procoagulant activity of tumors based on experiments on cultured cells.
Similar content being viewed by others
References
Baici, A.; Gyger-Marazzi, M.; Straüli, P. Extracellular cysteine proteinase and collagenase activities as a consequence of tumor-host interaction in the rabbit V2 carcinoma. Invasion & Metastasis 4:13–27; 1984.
Curatolo, L.; Alessio, G.; Gambacorti Passerini, C., et al. Procoagulant activity of mouse and human cultured cells following various types of transformation. Int. J. Cancer 35:411–414; 1985.
Curatolo, L.; Balconi, G.; Borgia, R., et al. Fibrin clot retractile activity of mouse fibroblasts during growth and aging. In Vitro 16:731–737; 1980.
Curatolo, L.; Colucci, M.; Cambini, A. L., et al. Evidence that cells from experimental tumors can activate coagulation factor X. Br. J. Cancer 40:228–233; 1979.
Curatolo, L.; Erba, E.; Morasca, L. Culture induces the appearance of immortalized C3H mouse cell lines. In Vitro 20:597–601; 1984.
Curatolo, L.; Frascotti, G.; Ubezio, P., et al. Characterization of transformed cell lines evolving from a normal C3H line. Exp. Cell Biol. 1988, in press.
Donati, M. B.; Gambacorti-Passerini, C.; Casali, B., et al. Cancer procoagulant in human tumor cells: evidence from melanoma patients. Cancer Res. 46:6471–6474; 1986.
Donati, M. B.; Poggi, A. Malignancy and haemostasis. Br. J. Haematol. 44:173–182; 1980.
Donati, M. B.; Semeraro, N. Cancer cell procoagulants and their pharmacological modulation. Haemostasis 14:422–429; 1984.
Dvorak, H. F.; Senger, D. R.; Dvorak, K. A. M. Fibrin as a component of the tumor stroma: origins and biological significance. Cancer Metast. Rev. 2:41–73; 1983.
Falanga, A.; Gordon, S. G. Comparison of properties of cancer procoagulant and human amnionon-chorion procoagulant. Biochim. Biophys. Acta 831:161–165; 1985.
Falanga, A.; Gordon, S. G. Isolation and characterization of cancer procoagulant: cysteine proteinase from malignant tissue. Biochemistry 24:5558–5567; 1985.
Author information
Authors and Affiliations
Additional information
This work was partially supported by the Italian National Research Council and by the Italian Association for Cancer Research.
An erratum to this article is available at http://dx.doi.org/10.1007/BF02624604.
Rights and permissions
About this article
Cite this article
Curatolo, L., Alessio, M.O., Casali, B. et al. Procoagulant activity of mouse transformed cells: Different expression in freshly isolated or cultured cells. In Vitro Cell Dev Biol 24, 1154–1158 (1988). https://doi.org/10.1007/BF02624183
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02624183